Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
China Pharmacy is Scopus-indexed (Q4, CiteScore 0.6), DOAJ. Published by Editorial Office of China Pharmacy.
Checked against the index lists dated .
ISSN 1001-0408Verify ISSN ↗
Publisher: Editorial Office of China Pharmacy
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 44 / 57 | 23rd | Q4 |
| Pharmaceutical Science | 157 / 191 | 18th | Q4 |
| Pharmacology | 288 / 328 | 12th | Q4 |
| Drug Discovery | 149 / 161 | 7th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q4, CiteScore 0.6.
China Pharmacy is Q4 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 44 of 57), Q4 in Pharmaceutical Science (rank 157 of 191) and Q4 in Pharmacology (rank 288 of 328), by CiteScore 2025. It is ranked in 4 subject areas in all.
China Pharmacy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.6, quartile Q4, 23rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.140, quartile Q4, with an H-index of 8.
China Pharmacy is published by Editorial Office of China Pharmacy. Its ISSN is 1001-0408.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
China Pharmacy has an h-index of 8 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #51 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
China Pharmacy published 17 papers in 2021; its busiest recent year was 2012 with 1,081. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.